Home
Offcial Website
About
About Help Therapeutics
Science
Help Therapeutics Institute
iPSC
iPSC Bank
Platform
Cellfoundry
Patients
All For Patient
Partners
Cooperation
Career
Join Help Therapeutics
+86 025-87177801 (China)
+1 347-204-4977 (US)
info@helptx.com.cn
News
Contact
Newsroom
Achievement
Achievement
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure
10/18/24
Achievement
Help Therapeutics iPSC-RPE program approved for provincial and municipal projects
8/8/22
Achievement
Help Therapeutics Named to Annual Technology Innovation List, Demonstrating the Company's "Hardcore Commitment"
1/24/22
Achievement
Help Therapeutics Ranked on the 2021 Biomedical Value Domains List, opening a new era in cell therapy
12/17/21
Achievement
Help Therapeutics Selected for National 13th Five-Year Plan Innovation Exhibition with Project Results
10/28/21
News
News
Circulation | Cardiac regeneration therapy adds to the list of evidence! Transplantation of hiPSCs-differentiated cardiomyocytes boosts active contractility by promoting injured heart function
11/16/22
News
Help Therapeutics partners with University of Macau to build joint lab
7/21/22
News
Help Therapeutics Completes Series C Financing of Hundreds of Millions of Dollars to Accelerate iPSC Global Footprint
11/15/21
News
Help Therapeutics Raises ¥50M in Series A+ Financing to Enter the 500B Heart Failure Market with "iPSC+Gene" Technology
10/15/20
